Cancer prevalence higher with long duration of diabetes

January 24, 2013
Cancer prevalence higher with long duration of diabetes
Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

Chaoyang Li, M.D., Ph.D., and colleagues from the U.S. Centers for Disease Control and Prevention in Atlanta, estimated the prevalence of diagnosed cancer using data for 25,964 adults with diagnosed diabetes from the 2009 Surveillance System.

The researchers found that, after adjustment for a number of variables, the prevalence of cancer was significantly higher with greater duration of diabetes. For adults with , the prevalence of cancer was significantly higher among those diagnosed with diabetes at least 15 years earlier (adjusted prevalence ratio, 1.6 for men and 1.8 for women). The prevalence of cancer of all sites was also higher among patients with type 2 diabetes who used insulin (1.3 for both men and women).

"While our cross-sectional results provide useful information for an association between duration of diagnosed diabetes or current insulin use and cancer prevalence, further clinical research with a longitudinal design is warranted to confirm a possible causal link between diabetes and cancer," Li and colleagues conclude.

Explore further: Increasing shift from islet antibody positivity to diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Increasing shift from islet antibody positivity to diabetes

March 2, 2012

(HealthDay) -- There is an increase in both the prevalence and levels of islet antigen-2 and zinc transporter 8, as well as in autoantibodies, in newly diagnosed type 1 diabetes patients during a period of rising disease ...

Diabetes linked to lung cancer in postmenopausal women

May 30, 2012

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Lung cancer risk unaffected by metformin use in diabetes

August 30, 2012

(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.

Recommended for you

Do germs cause type 1 diabetes?

May 16, 2016

Germs could play a role in the development of type 1 diabetes by triggering the body's immune system to destroy the cells that produce insulin, new research suggests.

Melatonin signaling is a risk factor for type 2 diabetes

May 12, 2016

A sleeping pancreas releases less insulin, but how much insulin drops each night may differ from person to person, suggests a study published May 12, 2016 in Cell Metabolism. Up to 30 percent of the population may be predisposed ...

New gene for familial high cholesterol

May 12, 2016

New research from Denmark reveals the gene that explains one quarter of all familial hypercholesterolemia with very high blood cholesterol. Familial hypercholesterolemia is the most common genetic disorder leading to premature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.